ClinicalTrials.govpublic full text
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
metabolic syndrome, bipolar depression, insulin resistance
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 300385
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.